[Federal Register Volume 75, Number 160 (Thursday, August 19, 2010)]
[Notices]
[Pages 51273-51275]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20572]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Expanded Human Immunodeficiency Virus (HIV) Testing for 
Disproportionately Affected Populations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

    Notice of Intent to increase funding available to make awards under 
the Centers for Disease Control and Prevention Funding Opportunity 
Announcement CDC-RFA-PS10-10138, ``Expanded Human Immunodeficiency 
Virus (HIV) Testing for Disproportionately Affected Populations''. 
Additional funding from the Patient Protection and Affordable Care Act 
has been allocated for awards to state and county and local public 
health departments with at least 175 estimated combined AIDS diagnoses 
among Blacks/African Americans and Hispanics/Latinos in 2007.
SUMMARY: This notice provides public notice of CDC's intent to increase 
available funding for the Centers for Disease Control and Prevention 
Funding Opportunity Announcement PS10-10138, ``Expanded Human 
Immunodeficiency Virus (HIV) Testing for Disproportionately Affected 
Populations'' to make awards to state and county and local public 
health departments. It is the intent of CDC to increase the amount of 
funds available to applicants who applied for awards under the 
previously announced funding opportunity CDC-RFA-PS10-10138, which 
closed on June 24, 2010.
    CDC received additional funding through the Patient Protection 
Affordable Care Act (PPACA), Section 4002 Prevention and Public Health 
Fund. Accordingly CDC adds the following information to the previously 
published funding opportunity announcement:
--Catalog of Federal Domestic Assistance Number: 93.523 The Affordable 
Care Act: Human Immunodeficiency Virus (HIV) Prevention and Public 
Health Fund Activities.
--Authority: This program is authorized under Sections 301 and 318 of 
the Public Health Service Act (42 U.S.C. Section 241 and 247c), as 
amended, and Section 4002 of the Patient

[[Page 51274]]

Protection and Affordable Care Act (Pub. L. 111-148).
--Reporting Requirements: Recipients of the PPACA funds through this 
funding opportunity announcement are required to comply with the 
reporting requirements, terms and conditions set forth in the published 
version of the PS10-10138, ``Expanded Human Immunodeficiency Virus 
(HIV) Testing for Disproportionately Affected Populations'' (CDC-RFA-
PS10-10138).
--CFDA Number 93.523 The Affordable Care Act: Human Immunodeficiency 
Virus (HIV) Prevention and Public Health Fund Activities is the PPACA-
specific CFDA number for this initiative. It is included in addition to 
the CFDA Number 93.940, HIV Prevention Activities for Health 
Departments, published in the above-referenced Funding Opportunity 
Announcement (FOA).
    Award Information:
    Type of Award: Cooperative Agreement.
    Fiscal Year Funds: Fiscal Year 2010, Funding for this announcement 
will include a combination of HIV Prevention funding and funds from the 
PPACA, Prevention and Public Health Fund. Available funding amounts, 
including the additional PPHF funds, are as follows.

Part A--HIV Screening and HIV Counseling, Testing, and Referral

    Approximate Current Fiscal Year Funding: Up to $60,000,000 total 
(to include up to $55,633,000 in Enhanced HIV Testing funds and adding 
$4,367,000 in Patient Protection and Affordable Care Act of 2010 
funds).
    Approximate Total Project Period Funding: $166,899,000. (This 
amount is an estimate, and is subject to availability of funds. This 
amount includes direct and indirect costs.)
    Approximate Number of Awards: 30.
    Approximate Average Award: $2,000,000. The average awards will be 
proportionately based on estimated combined 2007 Black/African American 
and Hispanic/Latino AIDS diagnoses for eligible jurisdictions. (These 
amounts are for the first 12-month budget period, and include both 
direct and indirect costs.)
    Floor and Ceiling of Individual Award Ranges:

------------------------------------------------------------------------
                                          Floor of       REVISED Ceiling
            Jurisdiction              individual award    of individual
                                            range         award range*
------------------------------------------------------------------------
Florida.............................        $4,307,446        $6,818,721
New York City.......................         3,998,517         6,329,161
California..........................         2,482,306         3,926,423
Texas...............................         2,094,529         3,311,912
New York State......................         1,861,862         2,943,206
Georgia.............................         1,788,184         2,826,449
Maryland............................         1,700,288         2,687,160
North Carolina......................         1,303,462         2,058,310
Louisiana...........................         1,302,170         2,056,262
Puerto Rico.........................         1,258,222         1,986,618
Houston.............................         1,197,470         1,890,344
District of Columbia................         1,140,596         1,800,216
New Jersey..........................         1,059,163         1,671,169
Philadelphia........................         1,042,359         1,644,540
South Carolina......................           985,485         1,554,411
Chicago.............................           968,681         1,527,782
Virginia............................           852,348         1,343,429
Los Angeles.........................           803,229         1,265,591
Pennsylvania........................           801,937         1,263,543
Michigan............................           798,059         1,257,398
Tennessee...........................           774,792         1,220,527
Illinois............................           707,578         1,114,012
Ohio................................           684,311         1,077,141
Massachusetts.......................           667,507         1,050,512
Alabama.............................           642,948         1,011,593
Mississippi.........................           605,463           952,191
Connecticut.........................           602,878           948,093
Missouri............................           549,881           864,111
Arizona.............................           542,126           851,820
San Francisco.......................           476,204           747,353
------------------------------------------------------------------------
* These ceilings are for the first 12-month budget period and include
  direct and indirect costs.

Part B--Enhanced Linkage to Medical Care and Partner Services

    Approximate Current Fiscal Year Funding: $4,000,000.
    Approximate Total Project Period Funding: $12,000,000 (This amount 
is an estimate, and is subject to availability of funds. This amount 
includes direct and indirect costs.)
    Approximate Number of Awards: Up to 20.
    Approximate Average Award: $200,000 (This amount is for the first 
12-month budget period, and includes both direct and indirect costs.)
    Floor of Individual Award Range: $ 150,000.
    Ceiling of Individual Award Range: $ 225,000 (This ceiling is for 
the first 12-month budget period and includes direct and indirect 
costs.)

Both Part A (HIV Screening and HIV Counseling, Testing, and Referral) 
and Part B (Enhanced Linkage to Medical Care and Partner Services)

    Anticipated Award Date: September 30, 2010.
    Budget Period Length: 12 months.
    Project Period Length: 3 years (Availability of PPACA funds beyond 
the initial 12 months will be based on availability of future funding.)

[[Page 51275]]

    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal government.

Application Selection Process

    CDC will apply the same selection methodology published in the CDC-
RFA-PS10-10138.

Funding Authority

    CDC will add the PPACA Authority to that which is currently 
reflected in the published Funding Opportunity CDC-RFA-PS10-10138. The 
revised funding authority language will read:
--This program is authorized under Sections 301 and 318 of the Public 
Health Service Act (42 U.S.C. Section 241 and 247c), as amended, and 
Section 4002 of the Patient Protection and Affordable Care Act (Pub. L. 
111-148).

DATES: The effective date for this action is August 19, 2010 and 
remains in effect until the expiration of the project period of the 
PPACA funded applications.

FOR FURTHER INFORMATION CONTACT: Elmira Benson, Acting Deputy Director, 
Centers for Disease Control and Prevention, 2920 Brandywine Road, 
Atlanta, GA 30341, telephone (770) 488-2802, e-mail: 
[email protected].

SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into 
law the Patient Protection and Affordable Care Act (PPACA), Public Law 
111-148. PPACA is designed to improve and expand the scope of health 
care coverage for Americans. Cost savings through disease prevention is 
an important element of this legislation and PPACA has established a 
Prevention and Public Health Fund (PPHF) for this purpose. 
Specifically, the legislation states in Section 4002 that the PPHF is 
to ``provide for expanded and sustained national investment in 
prevention and public health programs to improve health and help 
restrain the rate of growth in private and public sector health care 
costs.'' PPACA and the Prevention and Public Health Fund make improving 
public health a priority with investments to improve public health.
    The PPHF states that the Secretary shall transfer amounts in the 
Fund to accounts within the Department of Health and Human Services to 
increase funding, over the fiscal year 2008 level, for programs 
authorized by the Public Health Service Act, for prevention, wellness 
and public health activities including prevention research and health 
screenings, such as the Community Transformation Grant Program, the 
Education and Outreach Campaign for Preventative Benefits, and 
Immunization Programs.
    PPACA legislation affords an important opportunity to advance 
public health across the lifespan and to reduce health disparities by 
supporting an intensive community approach to chronic disease 
prevention and control.
    Therefore, increasing funding available to applicants under this 
FOA using the PPHF to further HIV prevention programs is consistent 
with the purpose of the PPHF, as stated above, to provide for an 
expanded and sustained national investment in prevention and public 
health programs. Further, the Secretary allocated funds to CDC, 
pursuant to the PPHF, for the types of activities this FOA is designed 
to carry out.

    Dated: August 13, 2010.
Tanja Popovic, MD, PhD, F(AMM), AM(AAFS),
Deputy Associate Director for Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-20572 Filed 8-18-10; 8:45 am]
BILLING CODE P